glp 1 agonist black box warning Liraglutide, the first long acting GLP-1RA was approved 12 years ago with a for MTC based on rodent data. After millions of Rx, registry and real world data show GLP-1 supplement claims: Regulatory considerations
Description
GIP also decreases postprandial glycemia and improves insulin sensitivity
In 14 patients with coronary artery disease and good LV function, intravenous GLP-1 infusion improved global and regional wall LV function on dobutamine stress echocardiography compared with control [92]
doi: 10.1016/j.bone.2012.11.039
Since then, numerous investigations have revealed the effects of GIP on multiple organs [14]
The revolution is underway, and with careful stewardship and continued research, GLP-1based strategies are poised to become an integral part of comprehensive, modern obesity care.
